Tag: Spallanzani Institute

First volunteer receives Italian anti-virus vaccine

  ROME, Italy (AFP) — An Italian hospital said on Monday it had innoculated a first volunteer with an anti-COVID-19 vaccine as part of human trials expected to last six months. The woman, in her 50s, received the first dose developed by Rome-based biotech company ReiThera at the capital’s Spallanzani Institute for infectious diseases. The trials, developed between ReiThera and Spallanzani researchers, will be carried out on 90 volunteers divided into groups by age to […]